22 Jan 2020 – Proactive interview – Destiny Pharma awaits key inflection point mid-2020 in its antimicrobial Phase 2b clinical trial

Posted on by Kirsty Richardson

Destiny Pharma CEO, Neil Clark, spoke with Proactive at the Biotech Showcase 2020 in San Francisco.  Please click here for video.